Adient (NYSE:ADNT – Free Report) had its price target decreased by JPMorgan Chase & Co. from $24.00 to $21.00 in a report published on Monday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Other equities analysts also recently issued research reports about the stock. StockNews.com downgraded shares of Adient from a “buy” rating to a “hold” rating in a research note on Wednesday, January 22nd. Barclays lowered their target price on Adient from $24.00 to $21.00 and set an “equal weight” rating for the company in a report on Wednesday, January 22nd. Bank of America lowered Adient from a “buy” rating to a “neutral” rating and cut their price target for the company from $30.00 to $24.00 in a research note on Thursday, November 21st. Morgan Stanley lowered their price objective on Adient from $21.00 to $19.00 and set an “underweight” rating for the company in a research note on Thursday, November 14th. Finally, Wells Fargo & Company lowered shares of Adient from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $27.00 to $20.00 in a report on Monday, December 16th. One research analyst has rated the stock with a sell rating and nine have given a hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $21.88.
View Our Latest Stock Report on ADNT
Adient Price Performance
Adient (NYSE:ADNT – Get Free Report) last released its earnings results on Tuesday, January 28th. The company reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.05). Adient had a return on equity of 6.86% and a net margin of 0.12%. During the same period in the prior year, the firm earned $0.31 EPS. On average, analysts anticipate that Adient will post 2.04 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, EVP James Conklin sold 11,500 shares of the stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $20.25, for a total transaction of $232,875.00. Following the transaction, the executive vice president now directly owns 51,829 shares of the company’s stock, valued at $1,049,537.25. This represents a 18.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.72% of the stock is owned by insiders.
Hedge Funds Weigh In On Adient
A number of institutional investors and hedge funds have recently made changes to their positions in ADNT. R Squared Ltd bought a new stake in shares of Adient during the fourth quarter worth about $32,000. US Bancorp DE boosted its stake in Adient by 583.8% during the 3rd quarter. US Bancorp DE now owns 1,860 shares of the company’s stock valued at $42,000 after purchasing an additional 1,588 shares during the last quarter. Versant Capital Management Inc increased its holdings in Adient by 10,316.7% during the 4th quarter. Versant Capital Management Inc now owns 1,875 shares of the company’s stock worth $32,000 after purchasing an additional 1,857 shares in the last quarter. Signaturefd LLC raised its stake in shares of Adient by 493.8% in the third quarter. Signaturefd LLC now owns 2,191 shares of the company’s stock worth $49,000 after purchasing an additional 1,822 shares during the last quarter. Finally, KBC Group NV lifted its holdings in shares of Adient by 51.8% in the third quarter. KBC Group NV now owns 3,328 shares of the company’s stock valued at $75,000 after purchasing an additional 1,136 shares in the last quarter. Institutional investors own 92.44% of the company’s stock.
Adient Company Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Read More
- Five stocks we like better than Adient
- The 3 Best Fintech Stocks to Buy Now
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- 3 Steel Stocks Soaring After Tariff Announcements
- What is the Dogs of the Dow Strategy? Overview and Examples
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.